NDC properties for NDC 9 61314-325
NDC item 61314032520
| NDC 9 | 61314-325 |
|---|---|
| NDC 10 | 61314-325-20 |
| NDC Item | 61314032520 |
| packaging | 2 SYRINGE in 1 CARTON (61314-325-20) / .8 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 866575 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-06 |
| Marketing status | ACTIVE |
NDC item 61314032596
| NDC 9 | 61314-325 |
|---|---|
| NDC 10 | 61314-325-96 |
| NDC Item | 61314032596 |
| BLA | BLA761071 |
| FDA SPL set id | 866575 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-06 |
| Marketing status | ACTIVE |